Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have developed a method allowing for the long-term culture of “pancreatic slices” to study the regeneration of the human pancreas in real time. The results, published recently in Nature Communications, demonstrate that extended cultures of near-intact human pancreatic tissue...
Multi-Center Study Addresses Impact of COVID-19 on People with Type 1 Diabetes
A study recently published in Diabetes Care focuses on individuals with type 1 diabetes who are suspected or confirmed to have contracted COVID-19 — the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19. “While diabetes has been identified as a risk factor for severe...
Cinnamon May Improve Blood Sugar Control in People with Prediabetes
Cinnamon improves blood sugar control in people with prediabetes and could slow the progression to type 2 diabetes, according to a new study published in the Journal of the Endocrine Society. It is estimated that nearly 90 million people in the U.S. have prediabetes, which occurs when blood sugar levels are higher than normal and often leads to type 2 diabetes. Identifying strategies...
The U.S. Food and Drug Administration (FDA) has approved insulin lispro-aabc injection, 100 units/mL and 200 units/mL, a new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. Eli Lilly and Company is marketing the drug as Lyumjev™. Lyumjev is a novel formulation of insulin lispro, developed to...
New App Helps Improve Diabetes Care in Patients with COVID-19
Last month, Endocrine News ran a feature about the need optimal glycemic control in patients hospitalized with COVID-19, which could require physicians treating these patients to take different approaches than usual. Now, an international group of healthcare experts have developed an app to help the providers on the front lines of caring for patients with...
As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. When this issue went to press, the U.S. had the most cases of COVID-19...
Consuming Sucralose with Carbohydrates May Impair Insulin Sensitivity, Study Finds
Consuming sucralose-sweetened beverages with carbohydrates may impair insulin sensitivity, according to a study recently published in Cell Metabolism. Researchers led by Dana M. Small, PhD, director of the Modern Diet and Physiology Research Center at Yale University in New Haven, Conn., point out that there is still significant controversy surrounding the effects of no- or...
Heart Attack, Stroke Risk Declines among People with Diabetes
Two-decade study shows overall mortality risk remains higher than general population The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in The Journal of Clinical...
